Halozyme Therapeutics Inc (HALO)
38.70
+0.06
(+0.16%)
USD |
NASDAQ |
Apr 22, 16:00
38.70
0.00 (0.00%)
After-Hours: 20:00
Halozyme Therapeutics Cash from Operations (TTM): 388.57M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 388.57M |
| September 30, 2023 | 368.67M |
| June 30, 2023 | 305.89M |
| March 31, 2023 | 279.28M |
| December 31, 2022 | 240.11M |
| September 30, 2022 | 240.17M |
| June 30, 2022 | 292.28M |
| March 31, 2022 | 288.94M |
| December 31, 2021 | 299.44M |
| September 30, 2021 | 267.84M |
| June 30, 2021 | 152.19M |
| March 31, 2021 | 118.59M |
| December 31, 2020 | 55.45M |
| September 30, 2020 | -22.09M |
| June 30, 2020 | -57.76M |
| March 31, 2020 | -85.84M |
| December 31, 2019 | -85.42M |
| September 30, 2019 | -48.34M |
| June 30, 2019 | -37.68M |
| March 31, 2019 | -31.75M |
| December 31, 2018 | -49.50M |
| September 30, 2018 | 93.29M |
| June 30, 2018 | 132.47M |
| March 31, 2018 | 134.34M |
| December 31, 2017 | 134.05M |
| Date | Value |
|---|---|
| September 30, 2017 | -34.96M |
| June 30, 2017 | -63.97M |
| March 31, 2017 | -59.82M |
| December 31, 2016 | -50.38M |
| September 30, 2016 | -49.81M |
| June 30, 2016 | -58.05M |
| March 31, 2016 | -36.27M |
| December 31, 2015 | -37.08M |
| September 30, 2015 | -22.82M |
| June 30, 2015 | -19.02M |
| March 31, 2015 | -43.73M |
| December 31, 2014 | -47.52M |
| September 30, 2014 | -61.80M |
| June 30, 2014 | -61.03M |
| March 31, 2014 | -56.22M |
| December 31, 2013 | -49.34M |
| September 30, 2013 | -50.99M |
| June 30, 2013 | -52.87M |
| March 31, 2013 | -55.67M |
| December 31, 2012 | -64.28M |
| September 30, 2012 | -60.91M |
| June 30, 2012 | -60.06M |
| March 31, 2012 | -42.57M |
| December 31, 2011 | -34.30M |
| September 30, 2011 | -28.17M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-85.84M
Minimum
Mar 2020
388.57M
Maximum
Dec 2023
155.81M
Average
240.11M
Median
Dec 2022
Cash from Operations (TTM) Benchmarks
| Johnson & Johnson | 22.79B |
| Globus Medical Inc | 243.50M |
| Denali Therapeutics Inc | -357.99M |
| AIM ImmunoTech Inc | -21.27M |
| Protalix BioTherapeutics Inc | -1.318M |